Published in HIV Med on May 01, 2005
Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infect Dis (2006) 0.83
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report. BMC Infect Dis (2006) 0.79
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study. J Neurovirol (2017) 0.75
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals. AIDS Res Treat (2016) 0.75
Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm (2016) 0.75
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (1982) 3.50
Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis (1999) 2.75
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp (1981) 2.15
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr (1999) 1.53
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods (1994) 1.46
Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun (1987) 1.45
Bacterial adherence--a pathogenetic mechanism in urinary tract infections caused by Escherichia coli. Prog Allergy (1983) 1.42
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. AIDS (1997) 1.39
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections. J Immunol (1985) 1.32
Intraarticular lesions in distal fractures of the radius in young adults. A descriptive arthroscopic study in 50 patients. J Hand Surg Br (1997) 1.28
V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology (1993) 1.24
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology (2007) 1.21
Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interferon Res (1990) 1.15
Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation. J Clin Invest (1980) 1.14
Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis (2000) 1.12
Acute viral encephalitis in adults--a prospective study. Scand J Infect Dis (1998) 1.10
Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand J Infect Dis (1986) 1.09
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS (1989) 1.08
Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol (1992) 1.06
Distal radioulnar instability is an independent worsening factor in distal radial fractures. Clin Orthop Relat Res (2000) 1.02
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J Clin Microbiol (1995) 1.01
Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Scand J Infect Dis (1986) 1.01
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels. Eur J Clin Pharmacol (2008) 1.00
Genetic factors in host resistance to urinary tract infection. Infection (1984) 0.99
Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients. J Neuroimmunol (2000) 0.97
Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachment in vivo and in vitro. Ann N Y Acad Sci (1983) 0.97
Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis. Clin Infect Dis (2000) 0.97
Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J Neurol Sci (1999) 0.96
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis (1994) 0.95
Antiretroviral treatment of central nervous system HIV-1 infection: a review. HIV Med (2001) 0.95
Fractures of the distal forearm in young adults. An epidemiologic description of 341 patients. Acta Orthop Scand (1999) 0.95
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis (1997) 0.94
Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. J Neurovirol (2001) 0.92
Ten years follow-up of health and disability in people with acute traumatic hand injury: pain and cold sensitivity are long-standing problems. J Hand Surg Eur Vol (2011) 0.91
Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and nonbacterial meningitis. J Infect Dis (2000) 0.91
Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob Agents Chemother (1989) 0.91
Chemical and clinical studies on the interaction of Escherichia coli with host glycolipid receptors in urinary tract infection. Scand J Infect Dis Suppl (1982) 0.91
Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett (2001) 0.90
Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions. J Neurol Sci (1988) 0.90
Diphtheria antitoxin titres six years after basic immunization of adults. Vaccine (1996) 0.90
Recent progress in the understanding of the role of bacterial adhesion in the pathogenesis of urinary tract infection. Infection (1983) 0.90
Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J Neurosci Res (1991) 0.90
Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens. Scand J Infect Dis (2000) 0.89
Post-operative management of flexor tendon grafting. J Hand Surg Br (1988) 0.88
Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res (1989) 0.88
Isolation of human immunodeficiency virus from cerebrospinal fluid of antibody-positive virus carrier without neurological symptoms. Lancet (1986) 0.88
Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem. Acta Neurol Scand (2008) 0.87
Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res Hum Retroviruses (1988) 0.87
Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. AIDS (1995) 0.86
The use of doxycycline in nervous system Borrelia burgdorferi infection. Scand J Infect Dis Suppl (1988) 0.86
Genetic factors in host resistance to urinary tract infection. Infection (1985) 0.86
Neurological efficacy of stavudine, zidovudine, and lamivudine. Lancet (1998) 0.85
Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. J Neuroimmunol (2001) 0.84
Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur J Neurol (1999) 0.83
Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.83
Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age. Pediatr Infect Dis J (1995) 0.83
Imaging of four-corner fusion (SLAC arthrodesis) of the wrist with 64-slice computed tomography. Acta Radiol (2007) 0.83
Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin Immunol Immunopathol (1990) 0.82
Non-antibiotic prevention of urinary tract infection. Infection (1984) 0.81
Non-antibiotic prevention of urinary tract infection. Infection (1985) 0.81
Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection. AIDS Res Hum Retroviruses (1994) 0.81
Adverse reactions and immunogenicity in adults to regular and increased dosage of diphtheria vaccine. Eur J Clin Microbiol (1987) 0.81
Interaction of a pyelonephritogenic Escherichia coli strain with the tissue components of the mouse urinary tract. J Urol (1986) 0.81
Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J Neurol Sci (1988) 0.81
Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis. Infection (1990) 0.80
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. Chest (1999) 0.80
Intestinal immune responsiveness in HIV-infected individuals. Adv Exp Med Biol (1995) 0.79
Fatal Serratia marcescens epiglottitis in a patient with leukaemia. J Infect (1987) 0.79
Prevention of restrictive adhesions with expanded polytetrafluoroethylene diffusible membrane following flexor tendon repair: an experimental study in rabbits. J Hand Surg Am (1998) 0.79
Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection. AIDS Res Hum Retroviruses (1996) 0.78
Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis. Infection (1996) 0.78
Intestinal antibody responses to oral vaccination in HIV-infected individuals. AIDS (1993) 0.78
Ligament lengthening compared with simple division of the transverse carpal ligament in the open treatment of carpal tunnel syndrome. Scand J Plast Reconstr Surg Hand Surg (1997) 0.78
Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infection. J Neurovirol (1997) 0.78
Destructive chronic borrelia meningoencephalitis in a child untreated for 15 years. Scand J Infect Dis (1987) 0.78
Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. AIDS Res Hum Retroviruses (1998) 0.78
Hematogenously spread herpesviruses are detected as frequently as neuronally spread herpesviruses in cerebrospinal fluid by polymerase chain reaction assay. Clin Infect Dis (1999) 0.77
Slowed reaction time in HIV-1-infected patients without AIDS. Acta Neurol Scand (2000) 0.77
Higher HIV-1 RNA cutoff level required in cerebrospinal fluid than in blood to predict positive HIV-1 isolation. J Med Virol (2000) 0.76
Hemagglutination (fimbriae) and hydrophobicity in adherence of Serratia marcescens to urinary tract epithelium and contact lenses. Curr Microbiol (1992) 0.76
Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma. HIV Med (2009) 0.76
Induction and expression of intestinal humoral immunity in HIV-infected individuals: prospects for vaccination against secondary enteric infections. Pathobiology (1998) 0.76
Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy. Adv Exp Med Biol (1996) 0.76
Sensory function after median nerve decompression in carpal tunnel syndrome. Preoperative vs postoperative findings. J Hand Surg Br (1997) 0.76